SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lactose India informs about closure of trading window

19 Jan 2019 Evaluate

Pursuant to Code of Conduct for Prevention of Insider Trading of the Company, Lactose India has informed that the Trading Window shall remain closed for Directors, Officers and designated employees of the Company from 20th January, 2019 to 27th January, 2019 for the purpose of approval of re-appointment of Sangita Maheshwari (DIN: 00369898) as the Whole-time Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Lactose India Share Price

113.00 -4.55 (-3.87%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×